BZYR - BURZYNSKI RESEARCH INSTITUTE INC
0.013
0.002 16.154%
Share volume: 10,000
Last Updated: 05-11-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$0.01
0.00
0.19%
Summary score
52%
Profitability
35%
Dept financing
43%
Liquidity
0%
Performance
85%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 30-Sep-2022 - 30-Sep-2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-20464.96%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
4361.25%
Debt ratio change over timeo
0%
Current Ratio
0.02%
Quick Ratio
0%
Cash Position Ratio
0.02%
Short-term ratios 30-Sep-2025 - 30-Sep-2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-19801.61%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
4200.09%
Debt ratio change over timeo
0%
Current Ratio
0.03%
Quick Ratio
0%
Cash Position Ratio
0.02%
Last quarter ratios 30-Sep-2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-14519.29%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
3073.2%
Debt ratio change over time
0%
Current Ratio
0.03%
Quick Ratio
0%
Cash Position Ratio
0.03%
Performance ratios (change over 4 years) 30-Sep-2022 - 30-Sep-2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BZYR | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 0% | 20.77% | 4.26% | 0% |
| Return on assets | -20464.96% | 9.31% | 4.2% | 0% |
| Return on sales | 0% | 30.08% | 17.16% | 0% |
| Return on invested capital | 0% | 30.94% | 10.28% | 0% |
| Profitability | 0% | 100% | 39% | 0% |
| Total debt ratio | 4361.25% | 57.4% | 51.28% | 0% |
| Debt ratio change over time | 0% | 0.84% | -10.21% | 0% |
| Dept financing | 25% | 25% | 0% | 0% |
| Current Ratio | 0.03% | 1.17% | 2.76% | 0% |
| Quick Ratio | 0% | 0.86% | 2.57% | 0% |
| Cash Position Ratio | 0.02% | 0.16% | 1.29% | 0% |
| Liquididy | 0% | 16% | 75% | 0% |
| Short-term ratios | BZYR | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -19801.61% | 10.06% | 5.03% | 0% |
| Return on sales | 0% | 30.36% | 7.38% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 19% | 0% |
| Total debt ratio | 4200.09% | 53.06% | 49.71% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 0% | 0% | 0% |
| Current Ratio | 0.03% | 1.17% | 2.76% | 0% |
| Quick Ratio | 0% | 0.86% | 2.57% | 0% |
| Cash Position Ratio | 0.02% | 0.16% | 1.29% | 0% |
| Liquididy | 0% | 22% | 75% | 0% |